Navigating ALK-Positive Lung Cancer Treatment

This chapter explores the intricate management of young patients with ALK-positive lung cancer, emphasizing the implications of treatment decisions on their quality of life and future family planning. It examines the use of various therapies, including chemotherapy and immunotherapy, while addressing challenges such as drug resistance and the need for better detection methods. Additionally, the chapter touches on the emerging role of JAK inhibitors in managing immune-related adverse events associated with cancer treatments.